Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity.

MLA

Imamura, Michie, et al. “Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity.” International Journal of Molecular Sciences, vol. 21, no. 24, Dec. 2020. EBSCOhost, https://doi.org/10.3390/ijms21249632.

APA

Imamura, M., Higuchi, O., Maeda, Y., Mukaino, A., Ueda, M., Matsuo, H., & Nakane, S. (2020). Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity. International Journal of Molecular Sciences, 21(24). https://doi.org/10.3390/ijms21249632

Chicago

Imamura, Michie, Osamu Higuchi, Yasuhiro Maeda, Akihiro Mukaino, Mitsuharu Ueda, Hidenori Matsuo, and Shunya Nakane. 2020. “Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity.” International Journal of Molecular Sciences 21 (24). doi:10.3390/ijms21249632.